Charles Sermon
2023
In 2023, Charles Sermon earned a total compensation of $1.1M as General Counsel at Mereo BioPharma Group plc, a 15% increase compared to previous year.
Compensation breakdown
| Bonus | $162,104 |
|---|---|
| Option Awards | $362,923 |
| Salary | $415,651 |
| Stock Awards | $99,540 |
| Other | $48,031 |
| Total | $1,088,249 |
Sermon received $415.7K in salary, accounting for 38% of the total pay in 2023.
Sermon also received $162.1K in bonus, $362.9K in option awards, $99.5K in stock awards and $48K in other compensation.
Rankings
In 2023, Charles Sermon's compensation ranked 1,116th out of 2,983 executives tracked by ExecPay. In other words, Sermon earned more than 62.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,116 out of 2,983 | 63rd |
Division Manufacturing | 662 out of 1,637 | 60th |
Major group Chemicals And Allied Products | 450 out of 906 | 50th |
Industry group Drugs | 439 out of 869 | 50th |
Industry Pharmaceutical Preparations | 301 out of 627 | 52nd |
Source: SEC filing on April 24, 2024.
Sermon's colleagues
We found two more compensation records of executives who worked with Charles Sermon at Mereo BioPharma Group plc in 2023.